Compound 272
Identifiers
- Canonical SMILES:
COc1ccc(c(CN2CCC(CC2)N2CCc3c(C2)ncnc3NS(=O)(=O)c2ccc(N[C@H](CCN(C)C)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)c1)-c1ccc(Cl)cc1
- IUPAC name:
N-[7-[1-[[2-(4-chlorophenyl)-5-methoxyphenyl]methyl]piperidin-4-yl]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)benzenesulfonamide
- InChi:
InChI=1S/C45H51ClF3N7O5S3/c1-54(2)21-17-34(29-62-37-7-5-4-6-8-37)52-41-16-14-38(26-43(41)63(57,58)45(47,48)49)64(59,60)53-44-40-20-24-56(28-42(40)50-30-51-44)35-18-22-55(23-19-35)27-32-25-36(61-3)13-15-39(32)31-9-11-33(46)12-10-31/h4-16,25-26,30,34-35,52H,17-24,27-29H2,1-3H3,(H,50,51,53)/t34-/m1/s1
- InChiKey:
SEIDCGVQBYNKNC-UUWRZZSWSA-N
External links
51042428 |
External search
Bibliography (1)
Publication | Name |
---|---|
Karen Miller-Moslin, Bakary-Barry Toure, Michael Scott Visser, Naeem Yusuff, Novartis Ag. . Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer None. | 36 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 7.47 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 957.28 g/mol | |||
HBA | 12 | |||
HBD | 2 | |||
HBA + HBD | 14 | |||
AlogP | 6.63 | |||
TPSA | 137.07 | |||
RB | 17 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011029842 | 36 | BCL2 P10415 |
|
Biochemical assay | Surface Plasmon Resonance | pIC50 (half maximal inhibitory concentration, -log10) | 7.47 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4800 | Navitoclax | DB12340 | |
0.3831 | GDC-0349 | DB13072 | |
0.3761 | Presatovir | DB12165 | |
0.3742 | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE | DB06899 | |
0.3711 | Sulfaisodimidine | DB13283 | |
0.3654 | Nemorexant | DB15031 | |
0.3639 | Anatibant | DB05038 | |
0.3639 | Quinupristin | DB01369 | |
0.3628 | Ceritinib | DB09063 | |
0.3619 | Sulfametomidine | DB13485 | |
0.3614 | Elobixibat | DB12486 | |
0.3591 | N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE | DB07800 | |
0.3576 | Elismetrep | DB15287 | |
0.3575 | Lenacapavir | DB15673 | |
0.3573 | Nelivaptan | DB12643 |